DA-9801

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-9801, covering 2019-04-16 to 2020-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of DA-9801 to Treat Diabetic Neuropathy [Phase 2]